SMT201600471B - Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche - Google Patents

Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche

Info

Publication number: SMT201600471B
Authority: SM; San Marino
Prior art keywords: nalmefene; reduction; specific target; alcohol consumption; target populations
Prior art date: 2012-06-27

Application number

SM201600471T

Other languages

English (en)

Inventor

Lars Torup

Afsaneh Abbariki

Anna Bladstrom

Christine Persson

Didier Meulien

Per Sorensen

Thomas Jon Jensen

Jette Buch Ostergaard

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-06-27

Filing date

2016-12-27

Publication date

2017-03-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48703496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201600471(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-12-27 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2017-03-08 Publication of SMT201600471B publication Critical patent/SMT201600471B/it

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

SM201600471T 2012-06-27 2016-12-27 Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche SMT201600471B (it)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US201261664804P	2012-06-27	2012-06-27
US201261721539P	2012-11-02	2012-11-02
US201261736740P	2012-12-13	2012-12-13
US201361788810P	2013-03-15	2013-03-15
PCT/EP2013/063461 WO2014001427A1 (en)	2012-06-27	2013-06-27	Nalmefene for reduction of alcohol consumption in specific target populations

Publications (1)

Publication Number	Publication Date
SMT201600471B true SMT201600471B (it)	2017-03-08

Family

ID=48703496

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
SM20160471T SMT201600471T1 (it)	2012-06-27	2013-06-27	Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche.
SM20180164T SMT201800164T1 (it)	2012-06-27	2013-06-27	Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche
SM201600471T SMT201600471B (it)	2012-06-27	2016-12-27	Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
SM20160471T SMT201600471T1 (it)	2012-06-27	2013-06-27	Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche.
SM20180164T SMT201800164T1 (it)	2012-06-27	2013-06-27	Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche

Country Status (35)

Country	Link
US (4)	US20140005216A1 (it)
EP (5)	EP2866808B1 (it)
JP (3)	JP6258933B2 (it)
KR (1)	KR20150023396A (it)
CN (1)	CN104411313A (it)
AU (1)	AU2013283281B2 (it)
BR (1)	BR112014032555A2 (it)
CA (1)	CA2874703C (it)
CL (1)	CL2014003484A1 (it)
CO (1)	CO7160087A2 (it)
CY (3)	CY1118579T1 (it)
DK (3)	DK2866808T3 (it)
EA (1)	EA029908B1 (it)
ES (4)	ES3014068T3 (it)
FI (1)	FI3345604T3 (it)
HK (1)	HK1255683A1 (it)
HR (4)	HRP20161717T1 (it)
HU (4)	HUE063313T2 (it)
IL (1)	IL236035B (it)
LT (3)	LT2866808T (it)
ME (2)	ME03030B (it)
MX (1)	MX371373B (it)
MY (1)	MY166914A (it)
NZ (1)	NZ702191A (it)
PH (1)	PH12014502798A1 (it)
PL (4)	PL3138564T3 (it)
PT (3)	PT3138564T (it)
RS (2)	RS55456B1 (it)
RU (1)	RU2665373C2 (it)
SG (1)	SG11201408704WA (it)
SI (3)	SI3138564T1 (it)
SM (3)	SMT201600471T1 (it)
UA (1)	UA114199C2 (it)
WO (1)	WO2014001427A1 (it)
ZA (1)	ZA201409525B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20140005216A1 (en)	2012-06-27	2014-01-02	H. Lundbeck A/S	Nalmefene for reduction of alcohol consumption in specific target populations
JP6419780B2 (ja) *	2013-04-17	2018-11-07	ハー・ルンドベック・アクチエゼルスカベット	睡眠障害患者の治療のためのナルメフェン
US20170042887A1 (en)	2014-04-22	2017-02-16	Otsuka Pharmaceutical. Co., Ltd.	Combination of Brexpiprazole and Nalmefene and Use Thereof for Treating Substance-Related Disorders
US20170071590A1 (en) *	2015-09-10	2017-03-16	Suture Armor Llc	Suture anchor
KR102699603B1 (ko)	2018-04-20	2024-08-29	삼성전자주식회사	반도체 메모리 소자

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3814768A (en)	1971-11-26	1974-06-04	Lewenstein E	6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts
US4535157A (en)	1983-11-01	1985-08-13	Key Pharmaceuticals, Inc.	Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US5086058A (en) *	1990-06-04	1992-02-04	Alko Ltd.	Method for treating alcoholism with nalmefene
PL368612A1 (en) *	2001-08-14	2005-04-04	Biotie Therapies Corporation	Method of treating alcoholism or alcohol abuse
UA102128C2 (en)	2008-12-05	2013-06-10	Х. Луннбек А/С	Nalmefene hydrochloride dihydrate
WO2010136039A1 (en)	2009-05-25	2010-12-02	H. Lundbeck A/S	Preparation of nalmefene hydrochloride from naltrexone
JP6246589B2 (ja)	2010-11-05	2017-12-13	ハー・ルンドベック・アクチエゼルスカベット	ナルトレキソンの製造方法
TR201803744T4 (tr)	2011-03-31	2018-07-23	Imuneks Farma Ilac Sanayi Ve Ticaret Anonim Sirketi	Skleroderma tedavisinde kullanım için naltrekson içeren bileşimler.
US20140005216A1 (en)	2012-06-27	2014-01-02	H. Lundbeck A/S	Nalmefene for reduction of alcohol consumption in specific target populations

2013
- 2013-06-26 US US13/928,317 patent/US20140005216A1/en not_active Abandoned
- 2013-06-26 US US13/928,332 patent/US20140005217A1/en not_active Abandoned
- 2013-06-27 EP EP13732471.1A patent/EP2866808B1/en not_active Revoked
- 2013-06-27 ES ES23163177T patent/ES3014068T3/es active Active
- 2013-06-27 HU HUE17206034A patent/HUE063313T2/hu unknown
- 2013-06-27 BR BR112014032555A patent/BR112014032555A2/pt not_active Application Discontinuation
- 2013-06-27 SI SI201330973T patent/SI3138564T1/en unknown
- 2013-06-27 DK DK13732471.1T patent/DK2866808T3/en active
- 2013-06-27 JP JP2015519085A patent/JP6258933B2/ja active Active
- 2013-06-27 EP EP24221142.3A patent/EP4541421A3/en active Pending
- 2013-06-27 LT LTEP13732471.1T patent/LT2866808T/lt unknown
- 2013-06-27 WO PCT/EP2013/063461 patent/WO2014001427A1/en not_active Ceased
- 2013-06-27 ME MEP-2018-68A patent/ME03030B/me unknown
- 2013-06-27 DK DK17206034.5T patent/DK3345604T3/da active
- 2013-06-27 DK DK16187426.8T patent/DK3138564T3/en active
- 2013-06-27 PL PL16187426T patent/PL3138564T3/pl unknown
- 2013-06-27 EP EP16187426.8A patent/EP3138564B1/en not_active Revoked
- 2013-06-27 KR KR1020147035322A patent/KR20150023396A/ko not_active Abandoned
- 2013-06-27 EP EP17206034.5A patent/EP3345604B1/en active Active
- 2013-06-27 HR HRP20161717TT patent/HRP20161717T1/hr unknown
- 2013-06-27 LT LTEP17206034.5T patent/LT3345604T/lt unknown
- 2013-06-27 RS RS20161173A patent/RS55456B1/sr unknown
- 2013-06-27 SI SI201330449A patent/SI2866808T1/sl unknown
- 2013-06-27 HU HUE13732471A patent/HUE031110T2/en unknown
- 2013-06-27 FI FIEP17206034.5T patent/FI3345604T3/fi active
- 2013-06-27 NZ NZ702191A patent/NZ702191A/en not_active IP Right Cessation
- 2013-06-27 HR HRP20250329TT patent/HRP20250329T1/hr unknown
- 2013-06-27 EP EP23163177.1A patent/EP4223296B1/en active Active
- 2013-06-27 HU HUE23163177A patent/HUE070621T2/hu unknown
- 2013-06-27 CN CN201380034056.2A patent/CN104411313A/zh active Pending
- 2013-06-27 PL PL23163177.1T patent/PL4223296T3/pl unknown
- 2013-06-27 LT LTEP16187426.8T patent/LT3138564T/lt unknown
- 2013-06-27 RS RS20180359A patent/RS57046B1/sr unknown
- 2013-06-27 RU RU2014151156A patent/RU2665373C2/ru active
- 2013-06-27 ME MEP-2016-286A patent/ME02587B/me unknown
- 2013-06-27 EA EA201492152A patent/EA029908B1/ru not_active IP Right Cessation
- 2013-06-27 PT PT161874268T patent/PT3138564T/pt unknown
- 2013-06-27 PL PL13732471T patent/PL2866808T3/pl unknown
- 2013-06-27 SI SI201332054T patent/SI3345604T1/sl unknown
- 2013-06-27 HU HUE16187426A patent/HUE036272T2/hu unknown
- 2013-06-27 CA CA2874703A patent/CA2874703C/en active Active
- 2013-06-27 ES ES13732471.1T patent/ES2609122T3/es active Active
- 2013-06-27 PT PT172060345T patent/PT3345604T/pt unknown
- 2013-06-27 AU AU2013283281A patent/AU2013283281B2/en not_active Ceased
- 2013-06-27 ES ES17206034T patent/ES2950492T3/es active Active
- 2013-06-27 UA UAA201500199A patent/UA114199C2/uk unknown
- 2013-06-27 SG SG11201408704WA patent/SG11201408704WA/en unknown
- 2013-06-27 SM SM20160471T patent/SMT201600471T1/it unknown
- 2013-06-27 MX MX2014015488A patent/MX371373B/es active IP Right Grant
- 2013-06-27 HR HRP20230762TT patent/HRP20230762T8/hr unknown
- 2013-06-27 MY MYPI2014003570A patent/MY166914A/en unknown
- 2013-06-27 PT PT137324711T patent/PT2866808T/pt unknown
- 2013-06-27 SM SM20180164T patent/SMT201800164T1/it unknown
- 2013-06-27 ES ES16187426.8T patent/ES2663532T3/es active Active
- 2013-06-27 PL PL17206034.5T patent/PL3345604T3/pl unknown
2014
- 2014-12-02 IL IL236035A patent/IL236035B/en active IP Right Grant
- 2014-12-15 PH PH12014502798A patent/PH12014502798A1/en unknown
- 2014-12-22 CO CO14280546A patent/CO7160087A2/es not_active Application Discontinuation
- 2014-12-22 CL CL2014003484A patent/CL2014003484A1/es unknown
- 2014-12-23 ZA ZA2014/09525A patent/ZA201409525B/en unknown
2016
- 2016-04-07 US US15/093,097 patent/US9642849B2/en active Active
- 2016-12-27 SM SM201600471T patent/SMT201600471B/it unknown
2017
- 2017-01-03 CY CY20171100004T patent/CY1118579T1/el unknown
- 2017-03-22 US US15/466,024 patent/US10034874B2/en active Active
- 2017-09-22 JP JP2017182608A patent/JP2018039810A/ja not_active Withdrawn
2018
- 2018-02-28 HR HRP20180363TT patent/HRP20180363T1/hr unknown
- 2018-03-27 CY CY20181100346T patent/CY1120097T1/el unknown
- 2018-11-20 HK HK18114830.5A patent/HK1255683A1/en unknown
2019
- 2019-04-25 JP JP2019083718A patent/JP6857684B2/ja active Active
2023
- 2023-07-25 CY CY20231100359T patent/CY1126140T1/el unknown

Also Published As

Publication number	Publication date
KR20150023396A (ko)	2015-03-05
EP4223296C0 (en)	2025-01-29
CY1120097T1 (el)	2018-12-12
CO7160087A2 (es)	2015-01-15
HRP20180363T1 (hr)	2018-04-20
SI3138564T1 (en)	2018-04-30
LT3345604T (lt)	2023-08-10
RS55456B1 (sr)	2017-04-28
LT2866808T (lt)	2017-01-10
PL3138564T3 (pl)	2018-06-29
US20140005217A1 (en)	2014-01-02
IL236035A0 (en)	2015-01-29
HK1255683A1 (en)	2019-08-23
EP3345604A1 (en)	2018-07-11
HRP20230762T8 (hr)	2024-01-05
HRP20161717T1 (hr)	2017-02-10
EP4223296A3 (en)	2023-09-27
MY166914A (en)	2018-07-24
HK1208185A1 (en)	2016-02-26
ES2609122T3 (es)	2017-04-18
EP2866808A1 (en)	2015-05-06
HRP20250329T1 (hr)	2025-05-09
JP6258933B2 (ja)	2018-01-10
EP4541421A2 (en)	2025-04-23
BR112014032555A2 (pt)	2017-06-27
RU2014151156A (ru)	2016-08-20
ME02587B (me)	2017-06-20
DK3345604T3 (da)	2023-07-24
EP3345604B1 (en)	2023-06-07
HUE063313T2 (hu)	2024-01-28
PL3345604T3 (pl)	2023-08-28
MX371373B (es)	2020-01-28
PL4223296T3 (pl)	2025-04-14
JP2019163275A (ja)	2019-09-26
HUE070621T2 (hu)	2025-06-28
MX2014015488A (es)	2015-03-06
IL236035B (en)	2018-12-31
JP6857684B2 (ja)	2021-04-14
HUE036272T2 (hu)	2018-06-28
EP2866808B1 (en)	2016-11-02
HUE031110T2 (en)	2017-06-28
EA029908B1 (ru)	2018-05-31
EP4223296A2 (en)	2023-08-09
JP2018039810A (ja)	2018-03-15
NZ702191A (en)	2017-06-30
FI3345604T3 (fi)	2023-07-28
UA114199C2 (uk)	2017-05-10
EA201492152A1 (ru)	2015-11-30
PT3345604T (pt)	2023-07-17
US20140005216A1 (en)	2014-01-02
WO2014001427A1 (en)	2014-01-03
LT3138564T (lt)	2018-04-10
SMT201600471T1 (it)	2017-03-08
CA2874703C (en)	2022-08-23
SI3345604T1 (sl)	2023-08-31
US20180028526A1 (en)	2018-02-01
CY1126140T1 (el)	2023-11-15
CN104411313A (zh)	2015-03-11
PT2866808T (pt)	2017-01-03
AU2013283281B2 (en)	2017-04-20
EP3138564B1 (en)	2018-01-31
US9642849B2 (en)	2017-05-09
EP4541421A3 (en)	2025-06-18
DK2866808T3 (en)	2017-01-16
ES2950492T3 (es)	2023-10-10
SG11201408704WA (en)	2015-01-29
CL2014003484A1 (es)	2015-02-27
HRP20230762T1 (hr)	2023-10-13
ES3014068T3 (en)	2025-04-16
ES2663532T3 (es)	2018-04-13
DK3138564T3 (en)	2018-03-26
CY1118579T1 (el)	2017-07-12
EP3138564A1 (en)	2017-03-08
US10034874B2 (en)	2018-07-31
PH12014502798A1 (en)	2015-02-09
SMT201800164T1 (it)	2018-07-17
PL2866808T3 (pl)	2017-04-28
ZA201409525B (en)	2016-08-31
PT3138564T (pt)	2018-04-03
ME03030B (me)	2018-10-20
RS57046B1 (sr)	2018-05-31
JP2015521647A (ja)	2015-07-30
CA2874703A1 (en)	2014-01-03
RU2665373C2 (ru)	2018-08-29
SI2866808T1 (sl)	2017-01-31
AU2013283281A1 (en)	2014-12-11
EP4223296B1 (en)	2025-01-29
US20160375007A1 (en)	2016-12-29

Publication	Publication Date	Title
EP3008215A4 (en)	2017-01-25	Statistical analysis for non-invasive sex chromosome aneuploidy determination
DK3542843T3 (da)	2022-08-01	Engangsinjektionspen til flere anvendelser
EP2875758A4 (en)	2016-05-18	JUICER
SMT202100158T1 (it)	2021-05-07	Inibitori di dna-pk
DK2914965T3 (da)	2021-04-26	Aflukker til biologiske mikroobjekter
BR112015005410A2 (pt)	2017-07-04	artigo fotocrômico-dicróico
DK2670587T3 (da)	2019-09-30	Tabletpresse
GB201222625D0 (en)	2013-01-30	Improvements relating to tracking moving objects
EP2832108A4 (en)	2016-01-13	DYNAMIC SEARCH SERVICE
EP2868741A4 (en)	2016-03-23	AQUEOUS TREATMENT LIQUID
SMT201600471B (it)	2017-03-08	Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche
EP2869763A4 (en)	2016-03-09	MONITORING OF GLUCOSE CONSUMPTION
EP2832814A4 (en)	2015-12-23	Liquid refrigerant composition
DE112013003695A5 (de)	2015-04-16	Elektrolyseur
CO7020922A2 (es)	2014-08-11	Comprimido antiácido
BR112013013099A2 (pt)	2019-09-24	unidade de bomba
ES1077761Y (es)	2013-01-10	Soporte elevaplato
ES1094505Y (es)	2014-02-18	Pieza para separar el busto femenino
GB201319107D0 (en)	2013-12-11	Improvements relating to personal tracking identifiers
SMT201500031B (it)	2015-05-05	Formulazione di tobramicina
GB201222657D0 (en)	2013-01-30	Improvements relating to personal tracking identifiers
GB201211286D0 (en)	2012-08-08	Novel biological factor
TH1401003484A (th)	2016-06-07	องค์ประกอบไบโอแอคทีฟซึ่งมีแอดทิวิตีต้านการเสื่อมตามวัยของผม
ES1076953Y (es)	2012-08-16	Dispositivo para la construccion de marquesinas para rotulos comerciales
GB201114034D0 (en)	2011-09-28	Ashiur ayana ayana woman